Patents by Inventor Steven P. Govek

Steven P. Govek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HSD17B13 INHIBITORS AND USES THEREOF
    Publication number: 20240083853
    Abstract: Described herein are compounds that are HSD17B13 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with HSD17B13 activity.
    Type: Application
    Filed: September 29, 2021
    Publication date: March 14, 2024
    Inventors: Steven P. Govek, Andiliy G. Lai, Andrew R. Hudson, Nicholas D. Smith, Karensa L. Fasanya
  • HSD17B13 INHIBITORS AND USES THEREOF
    Publication number: 20240083861
    Abstract: Described herein are compounds that are HSD17B13 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with HSD17B13 activity.
    Type: Application
    Filed: September 29, 2021
    Publication date: March 14, 2024
    Inventors: Andrew R. Hudson, Steven P. Govek, Johnny Y. Nagasawa, Iriny Botrous, Nicholas D. Smith, Karensa L. Fasanya
  • HSD17B13 INHIBITORS AND USES THEREOF
    Publication number: 20240034736
    Abstract: Described herein are compounds that are HSD17B13 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with HSD17B13 activity.
    Type: Application
    Filed: September 29, 2021
    Publication date: February 1, 2024
    Inventors: Andrew R. Hudson, Steven P. Govek, Johnny Y. Nagasawa, Iriny Botrous, Nicholas D. Smith, Karensa L. Fasanya
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20230382913
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: July 17, 2023
    Publication date: November 30, 2023
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Karensa L. DOUGLAS, Andiliy G. LAI
  • Farnesoid X receptor agonists and uses thereof
    Patent number: 11773094
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Grant
    Filed: June 16, 2021
    Date of Patent: October 3, 2023
    Assignee: ORGANOVO, INC.
    Inventors: Nicholas D. Smith, Steven P. Govek, Karensa L. Douglas, Andiliy G. Lai
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20220089575
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: November 30, 2021
    Publication date: March 24, 2022
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA, Karensa L. DOUGLAS, Andiliy G. LAI
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20220081390
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: November 22, 2021
    Publication date: March 17, 2022
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20220056019
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: September 17, 2019
    Publication date: February 24, 2022
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA, Andiliy G. LAI, Karensa L. DOUGLAS
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20220054469
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: September 17, 2019
    Publication date: February 24, 2022
    Inventors: Nicholas D. SMITH, Steven P. GOVEK
  • Farnesoid X receptor agonists and uses thereof
    Patent number: 11236071
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: February 1, 2022
    Assignee: METACRINE, INC.
    Inventors: Nicholas D. Smith, Steven P. Govek, Johnny Y. Nagasawa, Karensa L. Douglas, Andiliy G. Lai
  • Farnesoid X receptor agonists and uses thereof
    Patent number: 11214538
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Grant
    Filed: May 12, 2020
    Date of Patent: January 4, 2022
    Assignee: METACRINE, INC.
    Inventors: Nicholas D. Smith, Steven P. Govek, Johnny Y. Nagasawa
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20210395253
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: June 16, 2021
    Publication date: December 23, 2021
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Karensa L. DOUGLAS, Andiliy G. LAI
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20210300875
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: January 19, 2021
    Publication date: September 30, 2021
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA
  • Farnesoid X receptor agonists and uses thereof
    Patent number: 11084817
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Grant
    Filed: September 17, 2019
    Date of Patent: August 10, 2021
    Assignee: METACRINE, INC.
    Inventors: Nicholas D. Smith, Steven P. Govek, Karensa L. Douglas, Andiliy G. Lai
  • Farnesoid X receptor agonists and uses thereof
    Patent number: 10961198
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: March 30, 2021
    Assignee: METACRINE, INC.
    Inventors: Nicholas D. Smith, Steven P. Govek, Johnny Y. Nagasawa
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20210032195
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: May 12, 2020
    Publication date: February 4, 2021
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA
  • Farnesoid X receptor agonists and uses thereof
    Patent number: 10703712
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: July 7, 2020
    Assignee: METACRINE, INC.
    Inventors: Nicholas D. Smith, Steven P. Govek, Johnny Y. Nagasawa
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20200131129
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: March 14, 2018
    Publication date: April 30, 2020
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA, Andiliy G. LAI
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20200131134
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: March 14, 2018
    Publication date: April 30, 2020
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20200131132
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: March 14, 2018
    Publication date: April 30, 2020
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA